Brain Cancer: Molecular Alterations and Emerging Trends in Neuropharmacology
International Journal of Molecular Sciences · 28.05.2026 · 27 (11) · 4880
DOI: 10.3390/ijms27114880 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.05.2026. Verfasst von Beata Leskova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, 040 01 Kosice, Slovakia. Hauptthemen laut MEDLINE: Brain Neoplasms, Neuropharmacology. Die Arbeit nennt 279 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VEGA, APVV, NextGenerationEU.
Abstract (Originalsprache)
Central nervous system (CNS) tumors represent a heterogeneous group of neoplasms associated with significant morbidity and mortality despite their relatively low incidence. Advances in the fifth edition of the World Health Organization (WHO) classification have emphasized the integration of histopathological, immunohistochemical, and molecular features, fundamentally transforming diagnostic and prognostic frameworks in neuro-oncology. This manuscript aims to provide an overview of CNS tumor biology, focusing on key diagnostic markers, genetic and epigenetic alterations, and emerging therapeutic strategies. It further describes recent advances in multi-omics approaches and artificial intelligence, which enable deeper characterization of tumor heterogeneity and support the development of precision medicine strategies. Finally, current and emerging therapeutic modalities, including combination therapies, targeted treatments, and novel molecular targets, are examined with emphasis on overcoming resistance mechanisms and improving clinical outcomes. Overall, the integration of molecular biology, advanced diagnostics, and innovative therapeutic approaches represents a critical step toward personalized management of CNS tumors and improved patient survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, 040 01 Kosice, Slovakia.
- Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.
- Department of Pathology, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, 040 01 Kosice, Slovakia.
- Department of Medical Pharmacology, School of Medicine, Health Sciences University, 34668 Istanbul, Türkiye.
- Department of Biology, Faculty of Science, Dokuz Eylul University, 35390 Izmir, Türkiye.
ORCID-Profile: Ilaria D'Agostino, Simona Mattova, Nicol Urbanska, Alzbeta Blicharova, Aylin Toplu, Muhammet Karaman, Terezia Kiskova-Simkova
Förderung
- VEGA
- APVV
- NextGenerationEU
- KEGA
- European Union—Next Generation EU
- COST
Zitieren
APA
Leskova, B., D'Agostino, I., Mattova, S., Urbanska, N., Blicharova, A., Simko, P., Toplu, A., Karaman, M., & Kiskova-Simkova, T. (2026). Brain Cancer: Molecular Alterations and Emerging Trends in Neuropharmacology. International Journal of Molecular Sciences, 27(11), 4880. https://doi.org/10.3390/ijms27114880
Vancouver
Leskova B, D'Agostino I, Mattova S, Urbanska N, Blicharova A, Simko P, et al. Brain Cancer: Molecular Alterations and Emerging Trends in Neuropharmacology. International Journal of Molecular Sciences. 2026;27(11):4880. doi:10.3390/ijms27114880
BibTeX
@article{Leskova2026,
author = {Leskova, Beata and D'Agostino, Ilaria and Mattova, Simona and Urbanska, Nicol and Blicharova, Alzbeta and Simko, Patrik and Toplu, Aylin and Karaman, Muhammet and Kiskova-Simkova, Terezia},
title = {Brain Cancer: Molecular Alterations and Emerging Trends in Neuropharmacology},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {4880},
doi = {10.3390/ijms27114880}
}
EUVIMED